Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
74.05
-0.27 (-0.36%)
At close: May 22, 2026, 4:00 PM EDT
72.88
-1.17 (-1.58%)
After-hours: May 22, 2026, 7:06 PM EDT
Spyre Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
6.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 886.00K | -1.44M | -61.96% |
| Dec 31, 2022 | 2.33M | -16.41M | -87.57% |
| Dec 31, 2021 | 18.74M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Corcept Therapeutics | 769.10M |
| Mirum Pharmaceuticals | 569.61M |
| Rhythm Pharmaceuticals | 217.17M |
| Protagonist Therapeutics | 74.06M |
| Kymera Therapeutics | 51.48M |
| Centessa Pharmaceuticals | 15.00M |
SYRE News
- 12 days ago - Spyre Therapeutics price target raised to $102 from $86 at Deutsche Bank - TheFly
- 18 days ago - Spyre Therapeutics price target raised to $97 from $64 at Citi - TheFly
- 18 days ago - Spyre Therapeutics price target raised to $107 from $92 at Stifel - TheFly
- 19 days ago - Spyre Therapeutics reports Q1 EPS (74c), consensus (65c) - TheFly
- 19 days ago - Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 19 days ago - Spyre Therapeutics Quarterly report: Q1 2026 - Filings
- 19 days ago - Spyre Therapeutics Earnings release: Q1 2026 - Filings
- 23 days ago - Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewsWire